Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Besifovir vs Tenofovir in Chronic Hepatitis B
NCT01937806Phase 3Unknown
- Sponsor
- Ildong Pharmaceutical Co Ltd
- Start
- Oct 2013
- Primary completion
- Feb 2016
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of besifovir dipivoxil maleate in Chronic Hepatitis B (CHB), sponsored by Ildong Pharmaceutical Co Ltd. Status: unknown.
02
Drugs
besifovir dipivoxil maleate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT01937806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01937806.